Table of Content

1 INTRODUCTION 40
1.1 OBJECTIVES OF THE STUDY 40
1.2 MARKET DEFINITION 40
1.3 MARKET SCOPE 41
1.3.1 MARKETS COVERED 41
FIGURE 1 GLOBAL METABOLOMICS MARKET SEGMENTATION 41
1.3.2 YEARS CONSIDERED FOR THE STUDY 42
1.4 CURRENCY 42
1.5 LIMITATIONS 42
1.6 STAKEHOLDERS 42
1.7 SUMMARY OF CHANGES 43

2 RESEARCH METHODOLOGY 44
2.1 RESEARCH DATA 44
2.1.1 SECONDARY DATA 44
2.1.2 PRIMARY DATA 45
FIGURE 2 BREAKDOWN OF PRIMARIES: METABOLOMICS MARKET 45
2.1.3 MARKET DATA ESTIMATION & TRIANGULATION 46
2.1.4 DATA TRIANGULATION 46
FIGURE 3 DATA TRIANGULATION METHODOLOGY 46
2.2 MARKET ESTIMATION METHODOLOGY 47
FIGURE 4 MARKET SIZE ESTIMATION (COMPANY REVENUE ANALYSIS-BASED ESTIMATION) 47
FIGURE 5 METABOLOMICS MARKET SIZE (USD MILLION) 47
FIGURE 6 METABOLOMICS MARKET: GROWTH RATE OF TOP COMPANIES (2018_2019) 48
FIGURE 7 METABOLOMICS MARKET: FINAL CAGR PROJECTIONS (2020_2025) 48
FIGURE 8 METABOLOMICS MARKET: CAGR PROJECTIONS FROM THE ANALYSIS OF DEMAND-SIDE DRIVERS AND OPPORTUNITIES 49
2.3 INDUSTRY INSIGHTS 49
2.4 ASSUMPTIONS FOR THE STUDY 50

3 EXECUTIVE SUMMARY 51
FIGURE 9 METABOLOMICS MARKET SHARE, BY PRODUCT & SERVICE, 2019 VS. 2025 (USD MILLION) 51
FIGURE 10 METABOLOMICS MARKET SHARE, BY APPLICATION, 2019 52
FIGURE 11 METABOLOMICS MARKET SIZE, BY INDICATION, 2020 VS. 2025 53
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE METABOLOMICS MARKET 54

4 PREMIUM INSIGHTS 55
4.1 METABOLOMICS MARKET OVERVIEW 55
FIGURE 13 INCREASING PHARMACEUTICALS R&D ACTIVITIES AND GROWING DEMAND FOR PERSONALIZED MEDICINE WILL FAVOR MARKET GROWTH 55
4.2 ASIA PACIFIC: METABOLOMICS MARKET SHARE, BY PRODUCT AND SERVICE AND BY COUNTRY (2019) 56
FIGURE 14 METABOLOMICS INSTRUMENTS SEGMENT ACCOUNTED FOR LARGER SHARE OF ASIA PACIFIC MARKET IN 2019 56
4.3 METABOLOMICS MARKET SIZE, BY DETECTION TOOLS 57
FIGURE 15 MASS SPECTROMETRY (MS) SEGMENT WILL CONTINUE TO DOMINATE THE MARKET 57
4.4 METABOLOMICS MARKET SHARE, BY SEPARATION TOOLS, 2020 VS. 2025 57
FIGURE 16 HPLC HOLDS THE LARGEST SHARE OF THE MARKET 57

5 MARKET OVERVIEW 58
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
FIGURE 17 METABOLOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
5.2.1 KEY MARKET DRIVERS 60
5.2.1.1 Availability of government and private funding for metabolomics research 60
5.2.1.2 Increasing pharmaceutical and biotech R&D expenditure 60
5.2.1.3 Growing demand for personalized medicine 61
5.2.2 KEY MARKET RESTRAINTS 62
5.2.2.1 Issues related to data examination and processing 62
5.2.2.2 High cost of tools and instruments 62
5.2.3 KEY MARKET OPPORTUNITIES 62
5.2.3.1 Biomarker development 62
5.2.3.2 Lucrative opportunities in emerging markets 63
5.2.4 KEY MARKET CHALLENGES 63
5.2.4.1 Complexity and diversity of biological samples 63
5.2.4.2 Dearth of skilled researchers 63
5.3 IMPACT OF COVID-19 ON GROWTH OF METABOLOMICS MARKET 64

6 INDUSTRY INSIGHTS 65
6.1 INTRODUCTION 65
6.2 INDUSTRY TRENDS 65
6.2.1 INCREASING ADOPTION OF HYPHENATED TECHNOLOGIES 65
6.2.2 TIE-UPS BETWEEN INSTRUMENT MANUFACTURERS AND RESEARCH LABORATORIES/ACADEMIC INSTITUTIONS 66
6.3 REGULATORY ANALYSIS 67
TABLE 1 REGULATORY STANDARD/APPROVAL REQUIRED FOR METABOLOMICS PRODUCTS, BY COUNTRY/REGION 68

7 TECHNOLOGY INVESTMENT POTENTIAL 69
7.1 INTRODUCTION 69
7.2 INVESTMENT CLIENT NETWORKS 69
7.3 FUNDING BODIES/INITIATIVES 69
7.4 ANALYSIS OF POTENTIAL AREAS FOR TECHNOLOGY INVESTMENT USING STRATEGIC EVALUATION 70
7.4.1 PARAMETERS CONSIDERED FOR EMERGING OPPORTUNITY EVALUATION 70
7.4.1.1 Level of attractiveness 70
7.4.1.2 Probability of success 71
7.4.2 OPPORTUNITY STRATEGIC EVALUATION ANALYSIS 71
7.4.3 DESCRIPTION OF OPPORTUNITIES 72
7.4.3.1 Viable (Quadrant 1) – Biomarker discovery and lead optimization in drug discovery 72
7.4.3.1.1 Biomarker discovery 72
7.4.3.1.2 Lead optimization in drug discovery 72
7.4.3.1.3 Toxicity testing 72
7.4.3.2 Promising (Quadrant 2) – Companion diagnostics for personalized medicine and nutrigenomics 73
7.4.3.2.1 Companion diagnostics for personalized medicine 73
7.4.3.2.2 Nutrigenomics 73
7.4.3.2.3 Agriculture 73
7.4.3.3 Challenges (Quadrant 3) – Environmental metabolomics 74
7.4.3.3.1 Environmental metabolomics 74
7.4.3.3.2 Functional genomics 74

8 METABOLOMICS MARKET SIZE, BY PRODUCT AND SERVICE 75
8.1 INTRODUCTION 76
TABLE 2 METABOLOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2020–2025 (USD MILLION) 76
8.2 METABOLOMICS INSTRUMENTS 76
TABLE 3 GLOBAL METABOLOMICS INSTRUMENTS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION) 77
TABLE 4 METABOLOMICS INSTRUMENTS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 77
TABLE 5 NORTH AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 77
TABLE 6 EUROPE: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 7 ASIA PACIFIC: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 78
TABLE 8 LATIN AMERICA: METABOLOMICS INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 79
8.2.1 SEPARATION TOOLS 79
TABLE 9 GLOBAL METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION) 79
TABLE 10 METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 80
TABLE 11 NORTH AMERICA: METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 80
TABLE 12 EUROPE: METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 81
TABLE 13 ASIA PACIFIC: METABOLOMICS SEPARATION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 81
TABLE 14 LATIN AMERICA: METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 82
8.2.2 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 82
8.2.2.1 Growing use of HPLC in high-growth applications to drive market growth 82
TABLE 15 GLOBAL HPLC MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 83
TABLE 16 NORTH AMERICA: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 83
TABLE 17 EUROPE: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 83
TABLE 18 ASIA PACIFIC: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 84
TABLE 19 LATIN AMERICA: HPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 84
8.2.3 GAS CHROMATOGRAPHY 84
8.2.3.1 Technological advancements in gas chromatography to drive adoption of GC in metabolome study 84
TABLE 20 GLOBAL GAS CHROMATOGRAPHY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 85
TABLE 21 NORTH AMERICA: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 85
TABLE 22 EUROPE: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 86
TABLE 23 ASIA PACIFIC: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 86
TABLE 24 LATIN AMERICA: GAS CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 87
8.2.4 ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY 87
8.2.4.1 Higher chromatographic efficiency and sensitivity of UPLC would drive market growth 87
TABLE 25 GLOBAL UPLC MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 88
TABLE 26 NORTH AMERICA: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 88
TABLE 27 EUROPE: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 88
TABLE 28 ASIA PACIFIC: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 89
TABLE 29 LATIN AMERICA: UPLC MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 89
8.2.5 CAPILLARY ELECTROPHORESIS 89
8.2.5.1 CE is used in pathology/clinical laboratories worldwide due to the low cost of reagents, enhanced accuracy, and ease of operation 89
TABLE 30 GLOBAL CAPILLARY ELECTROPHORESIS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 90
TABLE 31 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 90
TABLE 32 EUROPE: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 91
TABLE 33 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 91
TABLE 34 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 92
8.2.6 DETECTION TOOLS 92
TABLE 35 GLOBAL METABOLOMICS DETECTION TOOLS MARKET SIZE, BY TYPE, 2018–2025 (USD MILLION) 93
TABLE 36 GLOBAL METABOLOMICS DETECTION TOOLS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 93
TABLE 37 NORTH AMERICA: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 93
TABLE 38 EUROPE: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 94
TABLE 39 ASIA PACIFIC: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 94
TABLE 40 LATIN AMERICA: METABOLOMICS DETECTION TOOLS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 95
8.2.7 MASS SPECTROMETRY 95
8.2.7.1 Increasing use of mass spectrometry in cancer and genetic disease research is propelling its demand 95
TABLE 41 GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 96
TABLE 42 NORTH AMERICA: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 43 EUROPE: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 96
TABLE 44 ASIA PACIFIC: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 97
TABLE 45 LATIN AMERICA: MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 97
8.2.8 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 97
TABLE 46 GLOBAL NMR SPECTROSCOPY MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 98
TABLE 47 NORTH AMERICA: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 98
TABLE 48 EUROPE: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 99
TABLE 49 ASIA PACIFIC: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 99
TABLE 50 LATIN AMERICA: NMR SPECTROSCOPY MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 99
8.2.9 SURFACE-BASED MASS ANALYSIS 100
8.2.9.1 Applicability of surface-based mass analysis technology in a wide range of samples would drive its growth 100
TABLE 51 GLOBAL SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 100
TABLE 52 NORTH AMERICA: SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 100
TABLE 53 EUROPE: SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 101
TABLE 54 ASIA PACIFIC: SURFACE-BASED MASS ANALYSIS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 101
8.3 METABOLOMICS BIOINFORMATICS TOOLS & SERVICES 101
TABLE 55 GLOBAL METABOLOMICS BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY TYPE, 2019–2025 (USD MILLION) 102
TABLE 56 GLOBAL BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 102
TABLE 57 NORTH AMERICA: BIOINFORMATICS TOOLS & SERVICES MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 103
8.3.1 BIOINFORMATICS SERVICES 103
8.3.1.1 Bioinformatics services offer a simplified way to derive insights from metabolomics research 103
TABLE 58 GLOBAL BIOINFORMATICS SERVICES MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 104
8.3.2 BIOINFORMATICS TOOLS & DATABASES 104
8.3.2.1 Application of bioinformatics tools & databases in translational research to fuel market growth 104
TABLE 59 GLOBAL BIOINFORMATICS TOOLS & DATABASE MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 105

9 METABOLOMICS MARKET SIZE, BY APPLICATION 106
9.1 INTRODUCTION 107
TABLE 60 METABOLOMICS MARKET SIZE, BY APPLICATION, 2018–2025 (USD MILLION) 107
9.2 BIOMARKER DISCOVERY 107
TABLE 61 METABOLOMICS MARKET SIZE FOR BIOMARKER DISCOVERY, BY REGION, 2018–2025 (USD MILLION) 108
TABLE 62 NORTH AMERICA: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 108
TABLE 63 EUROPE: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 109
TABLE 64 ASIA PACIFIC: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 109
TABLE 65 LATIN AMERICA: BIOMARKER DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 110
9.3 DRUG DISCOVERY 110
TABLE 66 METABOLOMICS MARKET SIZE FOR DRUG DISCOVERY, BY REGION, 2018–2025 (USD MILLION) 110
TABLE 67 NORTH AMERICA: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 111
TABLE 68 EUROPE: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 111
TABLE 69 ASIA PACIFIC: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 111
TABLE 70 LATIN AMERICA: DRUG DISCOVERY METABOLOMICS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 112
9.4 TOXICOLOGY TESTING 112
TABLE 71 METABOLOMICS MARKET SIZE FOR TOXICOLOGY TESTING, BY REGION, 2018–2025 (USD MILLION) 112
TABLE 72 NORTH AMERICA: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 113
TABLE 73 EUROPE: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 113
TABLE 74 ASIA PACIFIC: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 113
TABLE 75 LATIN AMERICA: TOXICOLOGY TESTING METABOLOMICS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 114
9.5 NUTRIGENOMICS 114
TABLE 76 METABOLOMICS MARKET SIZE FOR NUTRIGENOMICS, BY REGION, 2018–2025 (USD MILLION) 115
TABLE 77 NORTH AMERICA: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 115
TABLE 78 EUROPE: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 116
TABLE 79 ASIA PACIFIC: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 116
TABLE 80 LATIN AMERICA: NUTRIGENOMICS METABOLOMICS MARKET SIZE, BY REGION, 2018–2025 (USD MILLION) 117
9.6 PERSONALIZED MEDICINE 117
TABLE 81 METABOLOMICS MARKET SIZE FOR PERSONALIZED MEDICINES, BY REGION, 2018–2025 (USD MILLION) 117
TABLE 82 NORTH AMERICA: PERSONALIZED MEDICINES METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 118
TABLE 83 EUROPE: PERSONALIZED MEDICINES METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 118
TABLE 84 ASIA PACIFIC: PERSONALIZED MEDICINES METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 118
9.7 FUNCTIONAL GENOMICS 119
TABLE 85 METABOLOMICS MARKET SIZE FOR FUNCTIONAL GENOMICS, BY REGION, 2018–2025 (USD MILLION) 119
TABLE 86 NORTH AMERICA: FUNCTIONAL GENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 119
TABLE 87 EUROPE: FUNCTIONAL GENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 120
TABLE 88 ASIA PACIFIC: FUNCTIONAL GENOMICS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 120
9.8 OTHER APPLICATIONS 120
TABLE 89 METABOLOMICS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION) 121
TABLE 90 NORTH AMERICA: OTHER APPLICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 121
TABLE 91 EUROPE: OTHER APPLICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 122
TABLE 92 ASIA PACIFIC: OTHER APPLICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 122

10 METABOLOMICS MARKET SIZE, BY INDICATION 123
10.1 INTRODUCTION 124
TABLE 93 METABOLOMICS MARKET SIZE, BY INDICATION, 2018–2025 (USD MILLION) 124
10.2 CANCER 124
TABLE 94 METABOLOMICS MARKET SIZE FOR CANCER, BY REGION, 2018–2025 (USD MILLION) 125
TABLE 95 NORTH AMERICA: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 125
TABLE 96 EUROPE: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 126
TABLE 97 ASIA PACIFIC: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 126
TABLE 98 LATIN AMERICA: CANCER METABOLOMICS MARKET SIZE, BY COUNTRY 2018–2025 (USD MILLION) 127
10.3 CARDIOVASCULAR DISORDERS 127
TABLE 99 METABOLOMICS MARKET SIZE FOR CARDIOVASCULAR DISORDERS, BY REGION, 2018–2025 (USD MILLION) 127
TABLE 100 NORTH AMERICA: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 128
TABLE 101 EUROPE: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 128
TABLE 102 ASIA PACIFIC: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 129
TABLE 103 LATIN AMERICA: CARDIOVASCULAR DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 129
10.4 NEUROLOGICAL DISORDERS 129
TABLE 104 METABOLOMICS MARKET SIZE FOR NEUROLOGICAL DISORDERS, BY REGION, 2018–2025 (USD MILLION) 130
TABLE 105 NORTH AMERICA: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 130
TABLE 106 EUROPE: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 131
TABLE 107 ASIA PACIFIC: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 131
TABLE 108 LATIN AMERICA: NEUROLOGICAL DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 132
10.5 METABOLIC DISORDERS 132
TABLE 109 METABOLOMICS MARKET SIZE FOR METABOLIC DISORDERS, BY REGION, 2018–2025 (USD MILLION) 132
TABLE 110 NORTH AMERICA: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 133
TABLE 111 EUROPE: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 133
TABLE 112 ASIA PACIFIC: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 133
TABLE 113 LATIN AMERICA: METABOLIC DISORDERS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 134
10.6 INBORN ERRORS OF METABOLISM 134
TABLE 114 METABOLOMICS MARKET SIZE FOR INBORN ERRORS OF METABOLISM, BY REGION, 2018–2025 (USD MILLION) 134
TABLE 115 NORTH AMERICA: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 135
TABLE 116 EUROPE: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 135
TABLE 117 ASIA PACIFIC: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 135
TABLE 118 LATIN AMERICA: INBORN ERRORS OF METABOLISM METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 136
10.7 OTHERS 136
TABLE 119 METABOLOMICS MARKET SIZE FOR OTHER INDICATIONS, BY REGION, 2018–2025 (USD MILLION) 136
TABLE 120 NORTH AMERICA: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 137
TABLE 121 EUROPE: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 137
TABLE 122 ASIA PACIFIC: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 137
TABLE 123 LATIN AMERICA: OTHER INDICATIONS METABOLOMICS MARKET SIZE, BY COUNTRY, 2018–2025 (USD MILLION) 138

11 METABOLOMICS MARKET SIZE, BY END USER 139
11.1 INTRODUCTION 140
TABLE 124 METABOLOMICS MARKET SIZE, BY END USER, 2018–2025 (USD MILLION) 140
11.2 ACADEMIC RESEARCH INSTITUTES 140
TABLE 125 METABOLOMICS MARKET SIZE FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018–2025 (USD MILLION) 141
TABLE 126 NORTH AMERICA: METABOLOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 141
TABLE 127 EUROPE: METABOLOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 141
TABLE 128 ASIA PACIFIC: METABOLOMICS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018–2025 (USD MILLION) 142
11.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 142
TABLE 129 METABOLOMICS MARKET SIZE FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018–2025 (USD MILLION) 142
TABLE 130 NORTH AMERICA: METABOLOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 143
TABLE 131 EUROPE: METABOLOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 143
TABLE 132 ASIA PACIFIC: METABOLOMICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION) 144
11.4 CONTRACT RESEARCH ORGANIZATIONS (CROS) 144
TABLE 133 METABOLOMICS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION) 144
11.5 OTHERS 145
TABLE 134 METABOLOMICS MARKET SIZE FOR OTHER END USER, BY REGION, 2018–2025 (USD MILLION) 145